The group’s research is centered around research themes at the interface of organic chemistry, chemical biology, and nanomedicine, offering a unique integration of approaches to develop new modular methods for generating biologically interesting entities. While direct impacts are expected in fields such as immunotherapy or synthetic biomaterials, the group’s ambition is to prepare diagnostic, therapeutic, and research tools that are broadly useful to the scientific community. The versatility of the processes developed paves the way for a multitude of applications with implications extending beyond the aforementioned research areas.